Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

New nanocarriers improve drug delivery for disease treatment.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

PRP therapy is more effective than minoxidil for treating hair loss from androgenetic alopecia.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Taking biotin supplements can be risky and often lacks evidence of effectiveness for skin, hair, and nail issues.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

At-home laser and light skin devices are less effective than professional ones, with limited scientific evaluation, but some show promise for wrinkles, hair growth, and acne.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

JAK inhibitors show promise for treating various skin diseases.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

St. John's Wort extract and oil safety in cosmetics is unclear; more data needed on photosensitization, toxicity, and human irritation.